Back to top

Image: Bigstock

Compared to Estimates, P&G (PG) Q3 Earnings: A Look at Key Metrics

Read MoreHide Full Article

For the quarter ended March 2026, Procter & Gamble (PG - Free Report) reported revenue of $21.24 billion, up 7.4% over the same period last year. EPS came in at $1.59, compared to $1.54 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $20.51 billion, representing a surprise of +3.52%. The company delivered an EPS surprise of +1.75%, with the consensus EPS estimate being $1.56.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how P&G performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
  • Organic Sales Growth (YoY change) - Beauty: 7% versus the five-analyst average estimate of 2.8%.
  • Organic Sales Growth (YoY change) - Grooming: 1% versus the five-analyst average estimate of 1.5%.
  • Organic Sales Growth (YoY change) - Total P&G: 3% versus the five-analyst average estimate of 1.9%.
  • Organic Sales Growth (YoY change) - Baby, Feminine & Family Care: 3% compared to the 1.9% average estimate based on five analysts.
  • Organic Sales Growth (YoY change) - Fabric & Home Care: 3% versus the five-analyst average estimate of 1.3%.
  • Organic Sales Growth (YoY change) - Health Care: 2% versus the five-analyst average estimate of 1.7%.
  • Net Sales- Beauty: $3.87 billion versus the six-analyst average estimate of $3.67 billion. The reported number represents a year-over-year change of +10.8%.
  • Net Sales- Grooming: $1.61 billion compared to the $1.55 billion average estimate based on six analysts. The reported number represents a change of +6.8% year over year.
  • Net Sales- Corporate: $225 million compared to the $199.01 million average estimate based on six analysts. The reported number represents a change of +13.6% year over year.
  • Net Sales- Fabric & Home Care: $7.4 billion compared to the $7.18 billion average estimate based on six analysts. The reported number represents a change of +6.6% year over year.
  • Net Sales- Baby, Feminine & Family Care: $5.06 billion versus $4.94 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +6.4% change.
  • Net Sales- Health Care: $3.07 billion versus the six-analyst average estimate of $2.98 billion. The reported number represents a year-over-year change of +6.7%.

View all Key Company Metrics for P&G here>>>

Shares of P&G have returned +2.3% over the past month versus the Zacks S&P 500 composite's +8.1% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Zacks' 7 Best Strong Buy Stocks (New Research Report)

Valued at $99, click below to receive our just-released report predicting the 7 stocks that will soar highest in the coming month.

Click Here, It's Really Free

Published in